In May 2006, medical regulators in Denmark issued a warning that signaled trouble for General Electric. Danish researchers noted that, over a four-year period, 25 patients in Denmark and Austria had suffered a rare and crippling disease after undergoing an MRI, the scanning procedure used to diagnose everything from brain tumors to blown knees. The patients had been injected with a GE dye that makes images more distinct. They all had weak kidneys before receiving the dye.
The GE product, Omniscan, has since been linked to other cases of the disease, which appears to affect only MRI patients who have kidney problems. Similar drugs made by Bayer and others have also been tied to the sometimes fatal ailment, nephrogenic systemic fibrosis.
Specter of MRI Disease Haunts GE
The US Food and Drug Administration (FDA) has approved the first at-home test for cervical cancer...
The deadly and drug-resistant fungus Candida auris is under close surveillance as health experts work to...
An Indiana University undergraduate, a psychiatric researcher and a digital arts alumnus are working to bring...
